Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 2

NCT04430179

Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

The investigators will investigate the efficacy of dupilumab in patients with severe eosinophilic CRSsNP who are resistant to the conventional treatment with in…

United States30 participantsStarted 2020-12-17

Treatment: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], Placebo